CBIO
Crescent Biopharma
CBIO
CBIO
28 hedge funds and large institutions have $100M invested in Crescent Biopharma in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$787K | |
| 2 | +$715K | |
| 3 | +$353K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$339K |
| 5 |
Blackstone Inc
New York
|
+$130K |
Top Sellers
| 1 | -$204K | |
| 2 | -$97K | |
| 3 | -$88K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$50.1K |
| 5 |
Goldman Sachs
New York
|
-$43K |